Daniela Kandioler

Vienna, 1090, Austria

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients.

Experiences with the standardized classification of surgical complications (Clavien-Dindo) in general surgery patients.

Journal: European surgery : ACA : Acta chirurgica Austriaca

Published: June 26, 2018

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.

Journal: European surgery : ACA : Acta chirurgica Austriaca

Published: April 05, 2018

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.

Standardized intraoperative application of an absorbable polysaccharide hemostatic powder to reduce the incidence of lymphocele after kidney transplantation - a prospective trial.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: March 02, 2018

TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.

TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.

Journal: Annals of the New York Academy of Sciences

Published: February 25, 2018

Stage-directed individualized therapy in esophageal cancer.

Stage-directed individualized therapy in esophageal cancer.

Journal: Annals of the New York Academy of Sciences

Published: March 31, 2016

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.

TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.

Journal: EBioMedicine

Published: April 27, 2015

Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?

Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?

Journal: Hepatology (Baltimore, Md.)

Published: March 23, 2015

TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.

TP53 germline mutation may affect response to anticancer treatments: analysis of an intensively treated Li-Fraumeni family.

Journal: Breast cancer research and treatment

Published: January 05, 2015

Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.

Assessing the TP53 marker type in patients treated with or without neoadjuvant chemotherapy for resectable colorectal liver metastases: a p53 Research Group study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: November 25, 2014

Strategy for prevention of cancers of the esophagus.

Strategy for prevention of cancers of the esophagus.

Journal: Annals of the New York Academy of Sciences

Published: October 01, 2014

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.

Journal: The Journal of thoracic and cardiovascular surgery

Published: September 05, 2013

Cytosine 5-Hydroxymethylation of the LZTS1 Gene Is Reduced in Breast Cancer.

Cytosine 5-Hydroxymethylation of the LZTS1 Gene Is Reduced in Breast Cancer.

Journal: Translational oncology

Published: July 24, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026